New Delhi : The Delhi High Court has barred the export of generic kidney and liver cancer medication, Sorefenat, manufactured by Natco Pharma Ltd on the plea of German drug major Bayer Corporation.
Justice Manmohan, however, gave liberty to Natco to seek the court’s permission to export the drug as and when it gets the nod from the Drug Controlling Authority.
The court also issued notice to the Centre, customs authorities and Natco, seeking their replies on the plea of Bayer which has alleged that the generic drug is being made under compulsory licence for sale in India and thus, it cannot be exported.
Bayer has sought directions to the customs authorities to seize and confiscate the consignment.
Mumbai Crime: 43-Year-Old Man Arrested For Attacking Former Colleague With Knife In Malabar Hill
Elgar Parishad Case: NIA Seeks To Impound Passports Of 5 Accused Ahead Of October 9 Hearing
Mumbai News: Former Lodha Group Director Rajendra Lodha Remanded To Judicial Custody In ₹85 Crore Fraud Case
UP Deputy CM Keshav Prasad Maurya Holds Janata Darshan In Lucknow
